CVIR Endovascular is the multidisciplinary open access journal of Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
It is the first open peer-reviewed journal in the field of endovascular interventions and is intended for all specialists working in the field of endovascular treatment.
No CLEARity about antithrombotic around endovascular treatment
Antithrombotic regimes around peripheral vascular interventions are currently mostly based on individual beliefs and some secondary data from studies with different endpoints. The problem is that antithrombotic regimes have several goals to meet; to prevent acute thrombotic complications, to prevent intimal hyperplasia to obtain better TLR, and to achieve secondary risk prevention for vascular disease in general. The latter is scientifically proven in large studies. The use of some sort of antithrombotic treatment is not disputed, but there is no uniformity and no scientific guidelines in peripheral arterial interventions. The CLEAR survey by Christopher Twine et al. is a call to start a large study to solve this problem.
CVIR Endovascular now indexed in PubMed Central!
We are pleased to announce that CVIR Endovascular is now indexed in PubMed Central (PMC). A testament to the journal’s quality and value within the endovascular IR field, this announcement
reflects well on the journal’s editors, reviewers and authors. Now that the journal is indexed in PMC, CVIR Endovascular will reach more IRs than
15% APC discount for CIRSE Members
To celebrate CVIR Endovascular's success, help reduce the financial costs for authors and encourage more CIRSE researchers to consider publishing open access, CIRSE now offers a 15% discount on the article processing charge (APC) for CVIR Endovascular to corresponding authors who are CIRSE members in good standing. In order to apply for this discount, please contact CVIR Endovascular’s Editorial Office at firstname.lastname@example.org before you submit your article.
Please note that the CIRSE discount cannot be combined with an institutional discount, or used for already published articles.
APC waiver for Letters to the Editor
Open access also means open discussion. Have your say and contribute to scientific discussion on endovascular treatments by submitting a Letter to the Editor critiquing a paper already published in CVIR Endovascular.
APC waivers available for this article type - contact email@example.com for details!
Reduced price for open access fees
CVIR Endovascular reduced the prices for all authors who submit to the journal and get their papers accepted for publishing. As of now on, article processing charges will be only €1,060/£990/$1,390 (plus VAT or local taxes where applicable).